Taiwan Biomaterial Co., Ltd. (TPEX:6649)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.10
-0.10 (-0.22%)
At close: Mar 27, 2026

Taiwan Biomaterial Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
58.93-1.73-10.1333.76-47.44
Depreciation & Amortization
16.6416.7916.9615.9810.21
Other Amortization
-0.90.910.920.85
Loss (Gain) From Sale of Assets
----0.04
Stock-Based Compensation
----0.26
Other Operating Activities
-0.44-10.82-0.250.01
Change in Accounts Receivable
-24.142.471.65-13.643.53
Change in Inventory
-18.757.84-30.64-7.82-4.06
Change in Accounts Payable
15.55-3.554.632.790.02
Change in Unearned Revenue
0.290.47---0.15
Change in Other Net Operating Assets
0.7-3.755.65-2.4410.44
Operating Cash Flow
48.7718.43-10.1629.31-26.29
Operating Cash Flow Growth
164.68%----
Capital Expenditures
-1.44-3.69-2.57-35.67-28.01
Sale of Property, Plant & Equipment
---0.07-
Sale (Purchase) of Intangibles
-1.7-0.96-0.64-1.81-1.69
Investment in Securities
9.9624.9616.97-88.5176.89
Other Investing Activities
0.130.210.235.371.14
Investing Cash Flow
6.9520.5313.98-120.5548.34
Long-Term Debt Repaid
-4.4-5.29-6.89-7.03-2.24
Net Debt Issued (Repaid)
-4.4-5.29-6.89-7.03-2.24
Issuance of Common Stock
---189.781.03
Common Dividends Paid
---8.4--
Other Financing Activities
1.74----
Financing Cash Flow
-2.66-5.29-15.29182.75-1.21
Net Cash Flow
53.0633.67-11.4791.520.84
Free Cash Flow
47.3314.74-12.74-6.36-54.3
Free Cash Flow Growth
221.06%----
Free Cash Flow Margin
21.47%15.26%-17.49%-5.00%-130.31%
Free Cash Flow Per Share
1.120.35-0.30-0.16-1.65
Cash Interest Paid
0.740.80.870.971.03
Cash Income Tax Paid
0.370.210.250.09-
Levered Free Cash Flow
25.668.13-12.64-60.21-17.57
Unlevered Free Cash Flow
26.128.63-12.09-59.6-16.93
Change in Working Capital
-26.353.48-18.71-21.19.78
Source: S&P Global Market Intelligence. Standard template. Financial Sources.